Literature DB >> 26997422

Factors associated with radiologic progression of non-cystic fibrosis bronchiectasis during long-term follow-up.

Jisoo Park1, Sejoong Kim2, Yeon Joo Lee2, Jong Sun Park2, Young-Jae Cho2, Ho Il Yoon2, Kyoung-Won Lee3, Choon-Taek Lee2, Jae Ho Lee2.   

Abstract

BACKGROUND AND
OBJECTIVE: Non-cystic fibrosis (CF) bronchiectasis is a chronic airway inflammatory disease, exhibiting a diverse array of clinical courses. The purpose of this study was to determine the factors that predict radiologic progression of non-CF bronchiectasis during a long-term follow-up.
METHODS: We reviewed the electronic medical records that included pulmonary function test data from non-CF bronchiectasis patients, who were older than 18 years of age with a follow-up of computerized tomography for more than 5 years. The original Bhalla score was used to determine the radiologic severity of non-CF bronchiectasis.
RESULTS: A total of 155 patients (mean age, 59.6 years; male, 45.2%) were included for the final analysis. The mean follow up time was 7.11 ± 1.42 (5-10) years. The baseline Bhalla score was 9.52 ± 3.14 (4-19), and the change of Bhalla score was 0.55 ± 1.14 (-2 to 5). The Bhalla score was increased in 56 patients (36.1%) but not in 99 patients (63.9%). The Bhalla score change was significantly associated with the age at diagnosis (p = 0.037), body mass index (BMI, p = 0.012), chronic infection of Pseudomonas aeruginosa (p = 0.005) or isolation of nontuberculous mycobacterium (p = 0.042) in respiratory specimens. In a multivariate analysis, BMI and isolation of P. aeruginosa were significantly related with the Bhalla score change.
CONCLUSION: The radiologic progression of non-CF bronchiectasis was associated with lower BMI and isolation of P. aeruginosa in respiratory specimens.
© 2016 Asian Pacific Society of Respirology.

Entities:  

Keywords:  Bhalla score; Pseudomonas aeruginosa; body mass index; bronchiectasis; radiologic progression

Mesh:

Year:  2016        PMID: 26997422     DOI: 10.1111/resp.12768

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  9 in total

Review 1.  Year in review 2016: Respiratory infections, acute respiratory distress syndrome, pleural diseases, lung cancer and interventional pulmonology.

Authors:  Marcos I Restrepo; James D Chalmers; Yuanlin Song; Christopher Mallow; Justin Hewlett; Fabien Maldonado; Lonny Yarmus
Journal:  Respirology       Date:  2017-02-28       Impact factor: 6.424

2.  Is There a Correlation between New Scoring Systems and Systemic Inflammation in Stable Bronchiectasis?

Authors:  Hikmet Coban; Adil Can Gungen
Journal:  Can Respir J       Date:  2017-11-15       Impact factor: 2.409

Review 3.  Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis.

Authors:  Ravishankar Chandrasekaran; Micheál Mac Aogáin; James D Chalmers; Stuart J Elborn; Sanjay H Chotirmall
Journal:  BMC Pulm Med       Date:  2018-05-22       Impact factor: 3.317

Review 4.  Assessing Response to Therapy for Nontuberculous Mycobacterial Lung Disease: Quo Vadis?

Authors:  Christopher Vinnard; Alyssa Mezochow; Hannah Oakland; Ross Klingsberg; John Hansen-Flaschen; Keith Hamilton
Journal:  Front Microbiol       Date:  2018-11-20       Impact factor: 5.640

5.  Exercise capacity in patients with cystic fibrosis vs. non-cystic fibrosis bronchiectasis.

Authors:  Ronen Bar-Yoseph; Anat Ilivitzki; Dan M Cooper; Michal Gur; Gur Mainzer; Fahed Hakim; Galit Livnat; Zeev Schnapp; George Shalloufeh; Merav Zucker-Toledano; Yael Subar; Lea Bentur
Journal:  PLoS One       Date:  2019-06-13       Impact factor: 3.240

Review 6.  Impact of Pseudomonas aeruginosa Infection on Patients with Chronic Inflammatory Airway Diseases.

Authors:  Marta Garcia-Clemente; David de la Rosa; Luis Máiz; Rosa Girón; Marina Blanco; Casilda Olveira; Rafael Canton; Miguel Angel Martinez-García
Journal:  J Clin Med       Date:  2020-11-24       Impact factor: 4.241

7.  Global prevalence of non-tuberculous mycobacteria in adults with non-cystic fibrosis bronchiectasis 2006-2021: a systematic review and meta-analysis.

Authors:  Yunchun Zhou; Wei Mu; Jihua Zhang; Shi Wu Wen; Smita Pakhale
Journal:  BMJ Open       Date:  2022-08-01       Impact factor: 3.006

8.  Nutrition and Markers of Disease Severity in Patients With Bronchiectasis.

Authors:  Katherine A Despotes; Radmila Choate; Doreen Addrizzo-Harris; Timothy R Aksamit; Alan Barker; Ashwin Basavaraj; Charles L Daley; Edward Eden; Angela DiMango; Kevin Fennelly; Julie Philley; Margaret M Johnson; Pamela J McShane; Mark L Metersky; Anne E O'Donnell; Kenneth N Olivier; Matthias A Salathe; Andreas Schmid; Byron Thomashow; Gregory Tino; Kevin L Winthrop; Michael R Knowles; Mary Leigh Anne Daniels; Peadar G Noone
Journal:  Chronic Obstr Pulm Dis       Date:  2020-10

9.  A "Parasite" in bronchiectasis and COPD research.

Authors:  Joan B Soriano; Rosa Girón
Journal:  Ann Transl Med       Date:  2020-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.